Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
Phase 1
Completed
- Conditions
- IPF
- Interventions
- Drug: Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids
- First Posted Date
- 2010-12-24
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- Michael Donahoe
- Target Recruit Count
- 9
- Registration Number
- NCT01266317
- Locations
- 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Oral Cyclosporine in Chronic Obstructive Pulmonary Disease
Phase 1
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Michael Donahoe
- Target Recruit Count
- 43
- Registration Number
- NCT00974142
- Locations
- 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
News
No news found